KCM Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.46M Sell
53,668
-86
-0.2% -$9.93K 0.21% 82
2025
Q4
$5.66M Sell
53,754
-2,014
-4% -$189K 0.18% 88
2025
Q3
$4.68M Sell
55,768
-785
-1% -$64.7K 0.15% 101
2025
Q2
$4.48M Sell
56,553
-1,108
-2% -$88.1K 0.15% 102
2025
Q1
$5.18M Sell
57,661
-14,125
-20% -$1.32M 0.19% 90
2024
Q4
$7.14M Sell
71,786
-4,040
-5% -$417K 0.25% 73
2024
Q3
$8.61M Sell
75,826
-573
-0.8% -$68.1K 0.29% 72
2024
Q2
$9.46M Sell
76,399
-131
-0.2% -$16.9K 0.34% 65
2024
Q1
$10.1M Buy
76,530
+4,226
+6% +$521K 0.37% 65
2023
Q4
$7.88M Sell
72,304
-1,847
-2% -$192K 0.31% 72
2023
Q3
$7.63M Buy
74,151
+1,947
+3% +$210K 0.33% 69
2023
Q2
$8.33M Sell
72,204
-2,333
-3% -$265K 0.33% 67
2023
Q1
$7.93M Buy
74,537
+6,152
+9% +$664K 0.32% 72
2022
Q4
$7.59M Buy
68,385
+912
+1% +$93.2K 0.33% 75
2022
Q3
$5.81M Buy
67,473
+2,457
+4% +$219K 0.27% 86
2022
Q2
$5.93M Buy
65,016
+157
+0.2% +$13.9K 0.26% 90
2022
Q1
$5.32M Sell
64,859
-614
-0.9% -$48.4K 0.19% 101
2021
Q4
$5.02M Buy
65,473
+1,305
+2% +$104K 0.17% 105
2021
Q3
$4.82M Buy
64,168
+2,567
+4% +$195K 0.19% 100
2021
Q2
$4.79M Buy
61,601
+2,450
+4% +$182K 0.19% 100
2021
Q1
$4.35M Buy
59,151
+3,131
+6% +$231K 0.19% 102
2020
Q4
$4.37M Buy
56,020
+5,387
+11% +$412K 0.21% 97
2020
Q3
$4.01M Sell
50,633
-6,136
-11% -$481K 0.22% 89
2020
Q2
$4.19M Sell
56,769
-12,289
-18% -$925K 0.24% 84
2020
Q1
$5.07M Sell
69,058
-811
-1% -$63.7K 0.34% 72
2019
Q4
$6.06M Buy
69,869
+1,968
+3% +$162K 0.33% 80
2019
Q3
$5.45M Buy
67,901
+5,616
+9% +$450K 0.32% 84
2019
Q2
$4.98M Buy
62,285
+12,306
+25% +$942K 0.3% 87
2019
Q1
$3.97M Sell
49,979
-2,312
-4% -$173K 0.26% 93
2018
Q4
$3.81M Buy
52,291
+4,331
+9% +$306K 0.25% 90
2018
Q3
$3.25M Sell
47,960
-890
-2% -$56.7K 0.19% 108
2018
Q2
$2.83M Sell
48,850
-771
-2% -$43.5K 0.17% 124
2018
Q1
$2.58M Sell
49,621
-77,675
-61% -$4.2M 0.16% 140
2017
Q4
$6.83M Sell
127,296
-12,866
-9% -$713K 0.4% 67
2017
Q3
$8.56M Sell
140,162
-5,864
-4% -$356K 0.52% 50
2017
Q2
$8.93M Sell
146,026
-3,965
-3% -$241K 0.56% 49
2017
Q1
$9.09M Sell
149,991
-4,040
-3% -$245K 0.58% 47
2016
Q4
$8.65M Sell
154,031
-331
-0.2% -$19.4K 0.58% 47
2016
Q3
$9.19M Buy
154,362
+3,572
+2% +$209K 0.63% 44
2016
Q2
$8.29M Buy
150,790
+842
+0.6% +$44.8K 0.58% 47
2016
Q1
$7.57M Buy
149,948
+5,753
+4% +$282K 0.56% 50
2015
Q4
$7.27M Sell
144,195
-7,243
-5% -$365K 0.57% 49
2015
Q3
$7.14M Buy
151,438
+3,491
+2% +$185K 0.59% 47
2015
Q2
$8.04M Sell
147,947
-2,921
-2% -$164K 0.64% 38
2015
Q1
$8.28M Buy
150,868
+18,148
+14% +$1.03M 0.66% 39
2014
Q4
$7.19M Buy
132,720
+9,845
+8% +$549K 0.6% 40
2014
Q3
$6.95M Buy
122,875
+711
+0.6% +$39.9K 0.64% 37
2014
Q2
$6.74M Buy
122,164
+11,727
+11% +$640K 0.63% 37
2014
Q1
$5.98M Buy
110,437
+2,825
+3% +$146K 0.62% 36
2013
Q4
$5.14M Buy
107,612
+3,160
+3% +$144K 0.56% 47
2013
Q3
$4.75M Sell
104,452
-4,841
-4% -$221K 0.57% 42
2013
Q2
$4.84M Buy
+109,293
New +$4.88M 0.59% 40

Other funds holding MRK

KCM Investment Advisors's MRK Position: Q1 2026 in Review

KCM Investment Advisors reduced its Merck (MRK) stake by 0.16% in Q1 2026, selling an estimated $9.93K and leaving 53,668 shares worth $6.46M. The position accounts for 0.21% of the portfolio, ranked #82.

KCM Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.1M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • KCM Investment Advisors held 53,668 shares of Merck worth $6.46M as of Q1 2026.
  • KCM Investment Advisors sold 86 Merck shares in Q1 2026, an estimated $9.93K.
  • Merck made up 0.21% of KCM Investment Advisors's portfolio in Q1 2026, its #82 holding.
  • KCM Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • KCM Investment Advisors's Merck position peaked at $10.1M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on KCM Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.